Dana-Farber’s Belfer Institute for Applied Cancer Science and Evotec Collaborate

News   May 01, 2013

 
Dana-Farber’s Belfer Institute for Applied Cancer Science and Evotec Collaborate
 
 
 
 

RELATED ARTICLES

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

DARPA Pours $65 Million Into Making CRISPR Safer

News

With one eye on potential bioterrorism threats, the Defense Advanced Research Projects Agency has announced $65 million in funding to seven projects around the USA.

READ MORE

BioAscent Announces New CEO and Plans to Expand Discovery Services Offering

News

BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE